Showing 41 - 60 results of 2,268 for search '"drug safety"', query time: 0.25s Refine Results
  1. 41
    Pharmacovigilance and assessment of drug safety reports during COVID 19

    Pharmacovigilance and assessment of drug safety reports during COVID 19 by Mira K Desai

    Published 2020-01-01
    “…To address the unmet medical need, the regulations are made flexible and convenient without any relaxation in drug safety reporting. The pharmacovigilance activities, especially adverse event reporting regardless of clinical trials or clinical practice should continue as usual because patient safety is the priority. …”
    Get full text
    Article
  2. 42
    Characteristics of drug safety alerts issued by the Spanish Medicines Agency

    Characteristics of drug safety alerts issued by the Spanish Medicines Agency by Eva Montané, Eva Montané, Javier Santesmases, Javier Santesmases

    Published 2023-01-01
    “…Objectives: To describe the characteristics of safety alerts issued by the Spanish Medicines Agency (AEMPS) and the Spanish Pharmacovigilance System over a 7-year period and the regulatory actions they generated.Methods: A retrospective analysis was carried out of drug safety alerts published on the AEMPS website from 1 January 2013 to 31 December 2019. …”
    Get full text
    Article
  3. 43
    What is the role of antineoplastic drug safety in reimbursement decision making?

    What is the role of antineoplastic drug safety in reimbursement decision making? by A. S. Kolbin, A. A. Kurylev

    Published 2018-11-01
    Subjects: “…drug safety…”
    Get full text
    Article
  4. 44
    Systematic review of antiepileptic drugs’ safety and effectiveness in feline epilepsy

    Systematic review of antiepileptic drugs’ safety and effectiveness in feline epilepsy by Marios Charalambous, Akos Pakozdy, Sofie F. M. Bhatti, Holger A. Volk

    Published 2018-03-01
    Get full text
    Article
  5. 45
    Real-world evidence in antiretroviral therapy: drug safety data

    Real-world evidence in antiretroviral therapy: drug safety data by Ana-Marta Silva, Marta Pereira, Cláudia Camila Dias, Ângela Ventura, Bernardo Sousa-Pinto

    Published 2020-05-01
    Get full text
    Article
  6. 46
    Therapeutical Management and Drug Safety in Mitochondrial Diseases—Update 2020

    Therapeutical Management and Drug Safety in Mitochondrial Diseases—Update 2020 by Francesco Gruosso, Vincenzo Montano, Costanza Simoncini, Gabriele Siciliano, Michelangelo Mancuso

    Published 2020-12-01
    Get full text
    Article
  7. 47
    Drug safety assessment in clinical trials: methodological challenges and opportunities

    Drug safety assessment in clinical trials: methodological challenges and opportunities by Singh Sonal, Loke Yoon K

    Published 2012-08-01
    “…Regulatory and academic partnerships should be fostered to provide an independent and transparent evaluation of drug safety.</p>…”
    Get full text
    Article
  8. 48
    Quantitative approaches to drug safety: The 2022 PSP special issue

    Quantitative approaches to drug safety: The 2022 PSP special issue by Eric A. Sobie

    Published 2022-05-01
    Get full text
    Article
  9. 49
    Uncertainty characterisation in action potential modelling for cardiac drug safety

    Uncertainty characterisation in action potential modelling for cardiac drug safety by Johnstone, R

    Published 2018
    “…Following a workshop in July, 2013 at the US Food and Drug Administration (FDA), the <em>Comprehensive in-vitro Proarrhythmia Assay</em> (CiPA) initiative was proposed to improve safety testing, led by a number of drug safety and regulatory bodies around the world. …”
    Thesis
  10. 50
    Weakened by strengths: drugs in solution, medication error and drug safety

    Weakened by strengths: drugs in solution, medication error and drug safety by Wheeler, D

    Published 2008
    Thesis
  11. 51
    Modelling and simulation of engineered cardiac tissue for drug safety testing

    Modelling and simulation of engineered cardiac tissue for drug safety testing by Jacqueline, M

    Published 2020
    Thesis
  12. 52
    Histopathology of preclinical toxicity studies : interpretation and relevance in drug safety evaluation /

    Histopathology of preclinical toxicity studies : interpretation and relevance in drug safety evaluation / by 253132 Greaves, Peter

    Published 2007
  13. 53
    Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients

    Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients by Alan O. Vázquez-Alvarez, Lorena Michele Brennan-Bourdon, Ana Rosa Rincón-Sánchez, María Cristina Islas-Carbajal, Selene G. Huerta-Olvera

    Published 2017-12-01
    Subjects:
    Get full text
    Article
  14. 54
    Why drug safety should not take a back seat to efficacy.

    Why drug safety should not take a back seat to efficacy. by Virginia Barbour, Jocalyn Clark, Susan Jones, Melissa Norton, Paul Simpson, Emma Veitch

    Published 2011-09-01
    Get full text
    Article
  15. 55
    Drug-safety reporting in Polish nursing practice-Cross sectional surveys.

    Drug-safety reporting in Polish nursing practice-Cross sectional surveys. by Agnieszka Zimmermann, Agata Flis, Aleksandra Gaworska-Krzemińska, Marsha N Cohen

    Published 2020-01-01
    “…<h4>Conclusions</h4>Nurses in Poland are insufficiently prepared to ensure drug safety conscientiously and responsibly. Training is required for Polish nurses. …”
    Get full text
    Article
  16. 56
    Social media as a source of information on drug safety and how to extract it

    Social media as a source of information on drug safety and how to extract it by I. I. Snegireva, A. S. Kazakov, E. Yu. Pasternak, K. E. Zatolochina, T. V. Romanova

    Published 2018-02-01
    Subjects:
    Get full text
    Article
  17. 57
    POST-MARKETING DRUG SAFETY RESEARCH: ANALYSIS OF RECOMMENDATIONS OF FOREIGN REGULATORS

    POST-MARKETING DRUG SAFETY RESEARCH: ANALYSIS OF RECOMMENDATIONS OF FOREIGN REGULATORS by E. V. Shubnikova, T. M. Bukatina, D. A. Kaperko, N. Yu. Velts, M. A. Darmostukova, A. S. Kazakov, I. I. Snegireva, E. O. Zhuravleva, G. V. Kutekhova

    Published 2018-09-01
    Get full text
    Article
  18. 58
    THE MATERIALS OF SCIENTIFIC-PRACTICAL CONFERENCE «THE PECULIARITIES OF ASSESSMENT OF DRUG SAFETY FOR PEDIATRICS»

    THE MATERIALS OF SCIENTIFIC-PRACTICAL CONFERENCE «THE PECULIARITIES OF ASSESSMENT OF DRUG SAFETY FOR PEDIATRICS» by article Editorial

    Published 2022-12-01
    Get full text
    Article
  19. 59
    DRUG SAFETY ASSESSMENT FOR CENOBAMATE A RECENTLY FDA-APPROVED ANTIEPILEPTIC

    DRUG SAFETY ASSESSMENT FOR CENOBAMATE A RECENTLY FDA-APPROVED ANTIEPILEPTIC by Beatrice Radu, Roberta Stoica, Calin Rusu, Florentina Cojocaru, Adela Banciu, Daniel Banciu, Bogdan Amuzescu

    Published 2023-10-01
    Get full text
    Article
  20. 60
    Cardiovascular implications of the COVID-19: Management of complications and drug safety concerns

    Cardiovascular implications of the COVID-19: Management of complications and drug safety concerns by Maliheh Hamidian, Ramin Ansari, Mohammad Mehdi Zarshenas, Farzaneh Foroughinia

    Published 2022-01-01
    Get full text
    Article

Search Tools: